跳至主要内容
临床试验/CTRI/2022/06/043013
CTRI/2022/06/043013已完成2/3 期

A Randomized, Prospective, Comparative Clinical Study to evaluate efficacy and safety of NANSHO Hair Oil in mild to moderate Hair loss in females.

Namaskar Ayurved Private Limited1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年6月6日最近更新:

试验速览

阶段
2/3 期
状态
已完成
入组人数
60
试验地点
1
主要终点
2.Comparative assessment of hair breakage by comb test

研究概览

简要总结

It is a randomized, prospective, comparative, clinical study to evaluate efficacy and safety of NANSHO HAIR OIL in mild to moderate hair loss in females. Subjects will be asked to apply approximately 10 ml of hair oil for minimum 3 times a week. The primary objectives of the study will be to assess hair fall by running finger test and hair breakage by comb test. The secondary objectives of the study will be to assess hair fall by Hair Pull test, hair growth, effect on dandruff, effect on quality of hair, global assessment of overall change by physician and subject and assessment of safety and adverse events on screening visit, baseline visit, day 15, day 30, day 45 and day 60.

Results and Conclusion:

NANSHO Hair oil was significantly effective inreducing hair fall in female subjects suffering from mild to moderate hairloss. NANSHO Hair oil was significantly effective in improving hair growth. Italso effectively improved hair density, appearance and smoothness of the hair,thickness of hair and overall quality of hair and reducing dandruff ofhair/scalp. NANSHO Hair oil was found to be dermatologically safe withoutproducing any adverse effects.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • 1.Subjects suffering from mild to moderate hair loss (40-140 Hair by Comb test and Finger Test).
  • 2.Subjects who are infrequent hair oil users 3.Subjects who are willing to give informed consent and ready to comply with the protocol 4.Subjects who are ready to provide regular follow ups till the completion of the study.

排除标准

  • 1.Subjects with severe Hair fall due to any clinically significant disorder/s like anemia, thyroid disorders etc.
  • 2.Subject with severe dermatological disorders of the scalp that might interfere with the study evaluation 3.Subjects with recent disease history like, malaria, typhoid, jaundice and scalp diseases and subjects who in the opinion of the investigator are not eligible for enrollment in the clinical study 4.Subjects who have regularly used anti-hair fall treatment with hair oils over the last 6 months.
  • 5.Subjects who have previously undergone hair transplantation procedures 6.Subjects on systemic steroids for more than 14 days within 2 months prior to enrollment.
  • 7.Subjects on immunosuppressive drugs 8.Known cases of Hypersensitivity to hair oil contents 9.Subjects who have participated in any other clinical study since last 3 months 10.Subjects who are reported pregnant/planning a pregnancy or lactating.
  • 11.Menopausal Women.

结局指标

主要结局

2.Comparative assessment of hair breakage by comb test

时间窗: Screening visit, Baseline visit, Day 15, Day 30, Day 45 and Day 60

1.Comparative assessment of hair fall by running finger test

时间窗: Screening visit, Baseline visit, Day 15, Day 30, Day 45 and Day 60

次要结局

  • 1.Comparative assessment of hair fall by Hair Pull test(2.Comparative assessment of hair growth)

研究者

申办方类型
Pharmaceutical industry-Indian

研究点 (1)

Loading locations...

相似试验